Core Laboratories (CLB) Expected to Announce Quarterly Earnings on Wednesday

Core Laboratories (NYSE:CLB) is projected to issue its Q3 2025 results after the market closes on Wednesday, October 22nd. Analysts expect the company to announce earnings of $0.18 per share and revenue of $130.9240 million for the quarter. Core Laboratories has set its Q3 2025 guidance at 0.180-0.220 EPS.Parties can check the company’s upcoming Q3 2025 earningsummary page for the latest details on the call scheduled for Thursday, October 23, 2025 at 8:30 AM ET.

Core Laboratories (NYSE:CLB) last announced its quarterly earnings data on Wednesday, July 23rd. The oil and gas company reported $0.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.18 by $0.01. Core Laboratories had a return on equity of 14.15% and a net margin of 5.73%.The firm had revenue of $130.16 million for the quarter, compared to analysts’ expectations of $129.19 million. During the same period last year, the business posted $0.22 earnings per share. The firm’s revenue for the quarter was down .3% on a year-over-year basis. On average, analysts expect Core Laboratories to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Core Laboratories Stock Performance

Shares of CLB opened at $11.35 on Monday. The business’s fifty day moving average price is $11.69 and its 200 day moving average price is $11.74. Core Laboratories has a 12-month low of $9.72 and a 12-month high of $21.83. The stock has a market capitalization of $532.06 million, a PE ratio of 18.30, a price-to-earnings-growth ratio of 6.27 and a beta of 1.38. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.27 and a quick ratio of 1.70.

Core Laboratories Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, August 25th. Shareholders of record on Monday, August 4th were paid a $0.01 dividend. This represents a $0.04 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date was Monday, August 4th. Core Laboratories’s dividend payout ratio (DPR) is presently 6.45%.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on the company. Wall Street Zen upgraded Core Laboratories from a “sell” rating to a “hold” rating in a research note on Saturday, July 26th. Stifel Nicolaus cut their target price on Core Laboratories from $13.00 to $12.00 and set a “hold” rating on the stock in a research note on Wednesday, July 16th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Core Laboratories in a research note on Wednesday, October 8th. Finally, Zacks Research upgraded Core Laboratories from a “strong sell” rating to a “hold” rating in a research note on Friday, August 15th. Three investment analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Core Laboratories currently has an average rating of “Reduce” and a consensus target price of $12.50.

Institutional Investors Weigh In On Core Laboratories

Hedge funds and other institutional investors have recently modified their holdings of the stock. Bank of America Corp DE grew its stake in shares of Core Laboratories by 37.6% in the 2nd quarter. Bank of America Corp DE now owns 231,813 shares of the oil and gas company’s stock valued at $2,670,000 after buying an additional 63,381 shares in the last quarter. Balyasny Asset Management L.P. bought a new stake in shares of Core Laboratories in the 2nd quarter valued at approximately $586,000. Raymond James Financial Inc. grew its stake in shares of Core Laboratories by 14.2% in the 2nd quarter. Raymond James Financial Inc. now owns 221,465 shares of the oil and gas company’s stock valued at $2,551,000 after buying an additional 27,563 shares in the last quarter. Sei Investments Co. bought a new stake in shares of Core Laboratories in the 2nd quarter valued at approximately $231,000. Finally, American Century Companies Inc. grew its stake in shares of Core Laboratories by 14.3% in the 2nd quarter. American Century Companies Inc. now owns 133,033 shares of the oil and gas company’s stock valued at $1,533,000 after buying an additional 16,677 shares in the last quarter. 97.81% of the stock is currently owned by institutional investors.

About Core Laboratories

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.